Unmet Needs in LDL-C Lowering: When Statins Won’t Do!-Reference-Cited by-同舟云学术

Unmet Needs in LDL-C Lowering: When Statins Won’t Do!

Published:2016-07-25 Issue:12 Volume:76 Page:1175-1190
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Krähenbühl Stephan,Pavik-Mezzour Ivana,von Eckardstein Arnold

Funder

Funded by the institutions of the authors

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-016-0613-0.pdf

Reference135 articles.

1. European Cardiovascular Disease Statistics 2012 edition. http://www.escardio.org/The-ESC/Initiatives/EuroHeart/2012-European-Cardiovascular-Disease-Statistics . Last accessed Jan 2016.

2. Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidemias: the Task Force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32:1769–818.

3. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials. Lancet. 2010;376:1670–81.

4. Cholesterol Treatment Trialists’ (CTT) Collaboration. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–90.

5. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385:1397–405.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized, Parallel, Open‐Label, Single‐Dose and Multiple‐Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China;The Journal of Clinical Pharmacology;2024-08-19

2. New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments;Cureus;2024-06-24

3. Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib;The Journal of Clinical Pharmacology;2024-05-08

4. Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levels;npj Digital Medicine;2024-03-18

5. Meta-analysis comparing the effect of combined acupuncture plus statin therapy versus statin therapy alone on lipid levels of patients with angina pectoris of coronary heart disease;2024-02-16